Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)
South Korea · Delayed Price · Currency is KRW 5,020.00
+10.00 (0.20%)
At close: Oct 2, 2026
Kyung Dong Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 147,086 | 157,340 | 165,153 | 179,354 | 213,543 | 313,540 | |
Market Cap Growth | -6.52% | -4.73% | -7.92% | -16.01% | -31.89% | 1.02% |
Enterprise Value | 145,320 | 163,171 | 175,958 | 152,976 | 187,326 | 269,370 |
Last Close Price | 5020.00 | 5840.00 | 5828.03 | 5986.55 | 6707.81 | 9285.39 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 7.75 | 18.45 | 30.19 | - | 17.56 | 24.74 |
Forward PE | - | 12.11 | 12.11 | 12.11 | 12.11 | 12.11 |
PS Ratio | 0.73 | 0.80 | 0.85 | 1.10 | 1.17 | 1.77 |
PB Ratio | 0.64 | 0.69 | 0.75 | 0.79 | 0.83 | 1.21 |
P/TBV Ratio | 0.65 | 0.70 | 0.77 | 0.81 | 0.84 | 1.22 |
P/FCF Ratio | 31.94 | - | - | - | - | 36.90 |
P/OCF Ratio | 7.12 | 9.29 | - | - | - | 25.24 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.72 | 0.83 | 0.91 | 0.94 | 1.02 | 1.52 |
EV/EBITDA Ratio | 8.21 | 14.38 | 21.88 | - | 12.48 | 11.83 |
EV/EBIT Ratio | 10.59 | 21.29 | 67.07 | - | 22.54 | 17.09 |
EV/FCF Ratio | 31.55 | - | - | - | - | 31.70 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.11 | 0.20 | 0.18 | 0.07 | 0.10 | 0.02 |
Debt / EBITDA Ratio | 1.63 | 4.01 | 4.81 | - | 1.79 | 0.19 |
Debt / FCF Ratio | 5.58 | - | - | - | - | 0.51 |
Net Debt / Equity Ratio | -0.01 | -0.01 | 0.04 | -0.07 | -0.07 | -0.18 |
Net Debt / EBITDA Ratio | -0.13 | -0.14 | 0.97 | 0.87 | -1.22 | -2.01 |
Net Debt / FCF Ratio | -0.43 | 1.06 | -0.49 | 2.64 | 1.57 | -5.38 |
Asset Turnover | 0.66 | 0.63 | 0.65 | 0.54 | 0.61 | 0.61 |
Inventory Turnover | 1.66 | 1.81 | 2.02 | 2.27 | 2.90 | 2.71 |
Quick Ratio | 0.89 | 0.99 | 0.70 | 0.89 | 1.41 | 2.82 |
Current Ratio | 1.77 | 1.62 | 1.29 | 1.52 | 2.05 | 4.07 |
Return on Equity (ROE) | 7.97% | 3.76% | 2.43% | -8.53% | 4.68% | 4.83% |
Return on Assets (ROA) | 2.41% | 1.53% | 0.55% | -5.17% | 1.73% | 3.38% |
Return on Invested Capital (ROIC) | 4.32% | 3.12% | 1.19% | -11.06% | 2.47% | 5.17% |
Return on Capital Employed (ROCE) | 4.60% | 3.00% | 1.20% | -10.70% | 3.20% | 5.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 12.12% | 5.42% | 3.31% | -11.55% | 5.70% | 4.04% |
FCF Yield | 3.13% | -0.93% | -9.50% | -3.52% | -5.46% | 2.71% |
Dividend Yield | 5.98% | - | - | - | 5.96% | 5.38% |
Payout Ratio | 46.66% | 94.77% | 198.43% | - | 89.58% | 109.17% |
Buyback Yield / Dilution | -5.40% | -0.72% | 0.70% | 0.27% | 1.14% | -12.18% |
Total Shareholder Return | 0.57% | -0.72% | 0.70% | 0.27% | 7.11% | -6.79% |